• CDC
  • Heart Failure
  • Cardiovascular Clinical Consult
  • Adult Immunization
  • Hepatic Disease
  • Rare Disorders
  • Pediatric Immunization
  • Implementing The Topcon Ocular Telehealth Platform
  • Weight Management
  • Screening
  • Monkeypox
  • Guidelines
  • Men's Health
  • Psychiatry
  • Allergy
  • Nutrition
  • Women's Health
  • Cardiology
  • Substance Use
  • Pediatrics
  • Kidney Disease
  • Genetics
  • Complimentary & Alternative Medicine
  • Dermatology
  • Endocrinology
  • Oral Medicine
  • Otorhinolaryngologic Diseases
  • Pain
  • Gastrointestinal Disorders
  • Geriatrics
  • Infection
  • Musculoskeletal Disorders
  • Obesity
  • Rheumatology
  • Technology
  • Cancer
  • Nephrology
  • Anemia
  • Neurology
  • Pulmonology

Pulmonary Rehab in COPD: Mental Health & CV Considerations

Slideshow

Depression & anxiety in COPD patients respond well to pulmonary rehabilitation but how to proceed safely in patients with comorbid CVD?

Chronic obstructive pulmonary disease (COPD) and cardiovascular disease (CVD) are common comorbidities. In fact, COPD is linked to 2.5 times increased odds of CVD. Research suggests that patients with COPD undergoing pulmonary rehabilitation (PR) may experience reductions in depression and anxiety as well as improved cardiovascular and metabolic health. But to reap these benefits safely, patients with COPD need to be carefully screened for CV comorbidities before beginning PR and monitored during the program.The slides below summarize 2 recent studies on the impact of PR on mental health in COPD and how to assess CV fitness in COPD patients.

Recent Videos
New Research Amplifies Impact of Social Determinants of Health on Cardiometabolic Measures Over Time
Where Should SGLT-2 Inhibitor Therapy Begin? Thoughts from Drs Mikhail Kosiborod and Neil Skolnik
Related Content
© 2024 MJH Life Sciences

All rights reserved.